---
title: Virology
search_exclude: true
description: Data management solutions for virology data.
contributors: [Niels Geudens, Flora D'Anna]
page_id: virology
related_pages: 
  your_tasks: [data_provenance, metadata, data_brokering]
  tool_assembly: [covid19_data_portal]
# More information on which page id you can use can be found at https://rdmkit.elixir-europe.org/website_overview
training:
  - name:
    registry:
    url:
# More information on how to fill in this metadata section can be found here https://rdmkit.elixir-europe.org/page_metadata
---

## Introduction
Virology is a rapidly evolving field that generates diverse and complex datasets, from genomic sequences to clinical trial results and epidemiological data. Effective research data management (RDM) is essential to ensure that these valuable datasets are organized, shared, and preserved in a manner that enables data integration, reproducibility, and interoperability for long-term impact.

## Data Heterogeneity
 
### Description
Outbreak surveillance in virology requires the integration of multiple data types, including sequencing, clinical, and epidemiological data. These data types originate from diverse sources, such as hospitals, research laboratories, and public health agencies, making their harmonization and interoperability critical. Without standardized data management approaches, inconsistencies in metadata, sampling protocols, and data formats can hinder effective outbreak response, cross-study comparisons, and reproducibility of findings.

### Considerations
Key challenges in managing data heterogeneity include:
* Standardizing sample collection protocols across clinical and environmental settings to ensure comparability.
* Adopting structured, appropriate and sufficient  metadata to improve data annotation and organization .
* Integrating epidemiological and genomic data to enhance outbreak detection and integrative and global responses.

### Solutions
To effectively manage data heterogeneity in virology outbreak surveillance, several domain-specific solutions are recommended:
* The ['Data Provenance' page](https://rdmkit.elixir-europe.org/data_provenance) on RDMkit provides comprehensive guidance on capturing metadata, documenting data origins, and maintaining transparent records, ensuring data traceability and reproducibility.
* Use standardized protocols for sample collection by identifying and reviewing existing guidelines from organizations such as WHO, CDC, and ISO standards to ensure alignment with best practices.
* Implement metadata standards for data interoperability
  * the ['Documentation and metadata' page](https://rdmkit.elixir-europe.org/metadata_management) on RDMkit offers practical recommendations and standards for accurately describing data, ensuring consistent interpretation, interoperability, and long-term usability.
  * Apply {% tool "mixs" %} and the complementary [MIUVIG (Minimum Information about Uncultivated Virus Genomes)](https://www.nature.com/articles/nbt.4306) for annotating viral sequence data with necessary metadata fields.
  * Adapt Dublin Core Metadata Element Set for basic dataset descriptions such as title, creator, and date.
  * Follow {% tool "biosamples" %} Metadata Schema from EBI for structured viral sample metadata.
* Ensure metadata compliance with international repositories
  * the ['Data Brokering' page](https://rdmkit.elixir-europe.org/data_brokering) on RDMkit describes strategies and tools for integrating, harmonizing, and translating data across diverse formats and sources.
  * Format metadata to meet the submission requirements of repositories like {% tool "gisaid" %} and {% tool "european-nucleotide-archive" %} to ensure smooth data deposition and retrieval.
  * Utilize validation tools and checklists to ensure completeness and accuracy before data submission.
* FAIRsharing resources for metadata selection
  * Refer to the [EVORA collection](https://fairsharing.org/5449) of FAIRsharing-referenced metadata standards for pandemic preparedness and response.
  * Consult {% tool "fairsharing" %} registries to identify suitable standards for different types of virology datasets.
  * Integrate epidemiological and genomic data for outbreak analysis
  * Utilize phylodynamic workflows (e.g., BEAST, Nextstrain, or TreeTime) to combine genomic data with epidemiological models, enabling real-time outbreak tracking.
  * Implement structured pipelines for linking viral genome sequences with patient and outbreak metadata.
* Apply domain-specific vocabularies for consistent annotation
  * Utilize the [EVORA ontology](https://www.ebi.ac.uk/ols4/ontologies/evorao) and [ICTV ontologies](https://ictv.global/taxonomy) to ensure that virus-related metadata terms are standardized and interoperable.
  * Monitor updates in virology-specific ontologies to maintain alignment with evolving standards.
By implementing these best practices, outbreak surveillance data can be better structured, more interoperable, and more effectively shared, ultimately improving global response efforts to viral outbreaks.

## Data Sensitivity & Ethics
 
### Description
Handling sensitive data in virology outbreak surveillance involves managing patient data, ensuring proper anonymization, and complying with regulations such as the General Data Protection Regulation (GDPR). The ethical and legal aspects of handling such data are crucial to maintaining patient privacy while allowing researchers and public health authorities to analyze and respond to viral threats effectively.
Proper data governance strategies must balance the need for data accessibility and data security, ensuring that only authorized personnel can access identifiable information. Secure storage, controlled access mechanisms, and appropriate anonymization techniques must be implemented to meet legal and ethical standards.

### Considerations
Key challenges in managing data sensitivity and ethics include:
* Ensuring compliance with GDPR and other legal frameworks when collecting, processing, and sharing sensitive patient data.
* Anonymizing and pseudonymizing patient data to reduce privacy risks while preserving data utility for research.
* Implementing secure and scalable storage solutions that support controlled data access, encryption, and long-term preservation.

### Solutions
Organizations must implement robust governance policies, encryption techniques, and controlled data access mechanisms to maintain patient privacy while enabling scientific advancements. The following strategies outline best practices for secure data management and ethical compliance.
* Ensure GDPR and regulatory compliance
  * For guidance on managing sensitive data ethically and in compliance with regulations, the RDMkit pages on '[GDPR compliance](https://rdmkit.elixir-europe.org/gdpr_compliance)', '[Ethical aspects](https://rdmkit.elixir-europe.org/ethics)', and '[Compliance monitoring & measurement](https://rdmkit.elixir-europe.org/compliance_monitoring)' provide detailed recommendations on protecting personal data, navigating ethical responsibilities, and implementing effective compliance monitoring practices.
  * Conduct a Data Protection Impact Assessment (DPIA) to proactively identify and mitigate privacy risks associated with human and health-related data (see RDMkit Human data and Health data domain pages).
  * Utilize resources such as the Infectious Diseases Toolkit (IDTk) for detailed guidance on ethical, legal, and social implications related to handling sensitive data.
  * Establish clear data governance policies defining roles and responsibilities regarding data processing and sharing.
  * Ensure contractual coverage for data exchanges through appropriate agreements (e.g., Data Use Agreements, Consortium Agreements, Data Sharing Agreements), explicitly outlining data usage, retention, reuse, and publication policies. Material Transfer Agreements (MTAs) should similarly address the handling of human data derived from received samples.
  * When appropriate, employ specialized bioinformatics pipelines designed to remove human reads from genomic and transcriptomic virus datasets, rendering the data non-sensitive and suitable for open public sharing—an approach successfully implemented by initiatives such as the ENA upload tool for COVID-1
* Implement effective data anonymization and pseudonymization strategies
  * Refer to Your tasks: Data sensitivity | RDMkit?
* Adopt secure and scalable storage solutions
  * Refer to Your tasks: Data storage | RDMkit?
  * Store sensitive data in repositories designed for controlled access (e.g., EGA, ENA, ...
  * Use encryption for data at rest and in transit to prevent unauthorized access.
  * Establish strict access control policies, using role-based access and multi-factor authentication where appropriate.
* Implement best practices for data versioning and backup
  * Refer to Your tasks: Data organisation | RDMkit?
  * Use version control systems to track changes in datasets while maintaining data integrity.

## Data sharing and access
 
### Description
Effective data sharing and access enable timely surveillance of viral genome evolution, facilitating early detection of mutations and emerging variants. This rapid exchange of outbreak information supports swift global responses while simultaneously addressing critical concerns around data security and patient privacy. 
Researchers have a responsibility to share outbreak-related data ethically, legally, and efficiently, allowing authorized users appropriate access to sensitive materials, such as patient records and genomic sequences, in alignment with national and EU regulatory frameworks. Furthermore, assigning persistent identifiers and utilizing structured data repositories enhance the long-term usability, traceability, and discoverability of outbreak data, significantly improving preparedness and response strategies.

### Considerations
Key challenges in data sharing and access include:
* Balancing openness with security, ensuring that sensitive data is accessible to authorized users without compromising privacy.
* Adhering to national and international regulations to ensure ethical data sharing.
* Ensuring proper data deposition in repositories that align with domain-specific standards.
* Maintaining dataset integrity and discoverability using persistent identifiers like DOIs and accession numbers.

### Solutions
To ensure secure and effective data sharing in virology outbreak surveillance, researchers and institutions should implement structured strategies:
* Balance openness with security for data sharing
  * Refer to Your tasks: Data security | RDMkit and Your tasks: Data discoverability | RDMkit?
  * Use controlled-access repositories like VODAN - GO FAIR to manage and access sensitive patient or outbreak data securely.
  * Implement data access governance models that allow tiered access based on user credentials and need.
  * Utilize Pathoplexus for managing metadata and access rights in a structured manner. It is an open-source database dedicated to the efficient sharing of human viral pathogen genomic data, fostering global collaboration and public health response.
* Ensure proper deposition of outbreak data in trusted repositories
  * Refer to Your tasks: Data publication | RDMkit?
  * Submit viral genomic sequences and epidemiological data to GISAID, NCBI GenBank, and ENA for public accessibility.
  * Use standard submission pipelines to ensure compliance with repository-specific metadata and formatting guidelines.
* Assign persistent identifiers for dataset discoverability
  * Refer to Your tasks: Identifiers | RDMkit
  * Register DOIs or accession numbers for datasets to facilitate long-term accessibility and proper citation.
  * Ensure metadata linking persistent identifiers is properly formatted and recorded.
* Comply with national and EU data-sharing regulations
  * Refer to National resources | RDMkit?
  * Align data-sharing practices with GDPR, national laws, and institutional ethical guidelines.
  * Implement data-sharing agreements between collaborating institutions to formalize responsibilities.

